The expression levels of Nischarin were previously demonstrated to be significantly higher in normal breast tissue compared with breast cancer tissue, and the loss of Nischarin expression in breast cancer tissue is hypothesized to be due to a loss of heterozygosity (26). Here, NISCH is linked to breast carcinoma.